Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy, Alzheimer Disease

In brief

The purpose of this study is to investigate the safety of a single dose of Lu AF87908, how well it is tolerated and what the body does to the drug in healthy participants and participants with Alzheimer's disease.

Key facts

Study ID
NCT04149860
Run by
H. Lundbeck A/S
People needed
86
Starts
2019-09-27
Expected to finish
2023-07-19
Last updated by the study team
2023-08-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.